Joint Hypermobility and Anxiety: The State of the Art

Abstract

Joint hypermobility (JH) is considered a common benign, hereditary, overlap, connective tissue disorder with a prevalence in the general population of about 10% in European populations and 25% in other ethnic groups. JH shows an association with mitral valve prolapse and fibromyalgia. However, the most significant and important association between joint hypermobility syndrome (JHS) and any other disorder from a clinical point of view is with panic disorder. This article summarizes all published studies on JHS and anxiety, analyzing the main results and limitations. An overview of the etiologic explanation of the association between JH and anxiety, with special focus on genetic findings, is also included. The most relevant conclusions are the following: JHS is more prevalent in individuals with panic disorder/agoraphobia, and patients with JHS present with greater prevalence of panic disorder/agoraphobia. In addition, there is an association between JHS severity and severity of anxiety, and mitral valve prolapse plays a secondary role in the association between JHS and anxiety. New fields of research based on these data are suggested.

This is a preview of subscription content, log in to check access.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.

    Beighton PH, Grahame R, Bird H: Hypermobility of Joints, edn 2. London: Springer-Verlag; 1989.

    Google Scholar 

  2. 2.

    Sutro J: Hypermobility of knees due to overlengthed capsular and ligamentous tissues. Surgery 1947, 21:67–76.

    CAS  PubMed  Google Scholar 

  3. 3.

    Kirk JH, Ansell B, Bywaters EGL: The hypermobility syndrome. Ann Rheum Dis 1967, 26:419–425.

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Grahame R: Hypermobility syndrome. In Rheumatology, vol II, edn 2. Edited by Kipplel JH, Dieppe PA. London: Mosby; 1997:1–6.

    Google Scholar 

  5. 5.

    Winne-Davies R: Familial joint laxity. Proc R Soc Med 1971, 64:689.

    Google Scholar 

  6. 6.

    Carter C, Wilkinson J: Persistent joint laxity and congenital dislocation of the hip. J Bone Joint Surg 1964, 46:40–45.

    CAS  Google Scholar 

  7. 7.

    Beighton PH, Solomon L, Soskolne CL: Articular mobility in an African population. Ann Rheum Dis 1973, 32:413–418.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    De Coster PJ, Van den Berghe LI, Martens LC: Generalized joint hypermobility and temporomandibular disorders: inherited connective tissue disease as a model with maximum expression. J Orofac Pain 2005, 19:47–57.

    PubMed  Google Scholar 

  9. 9.

    Mishra MB, Ryan P, Atkinson P, et al.: Extra-articular features of benign joint hypermobility syndrome. Br J Rheumatol 1996, 35:861–866.

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Bird HA: Articular and tissue laxity. Rheumatol Rev Rep 1984, 4:11–22.

    Google Scholar 

  11. 11.

    Al-Rawi Z, Al-Rawi Z: Joint hypermobility in women with genital prolapse. Lancet 1982, i:1439–1441.

    Article  Google Scholar 

  12. 12.

    Bulbena A, Martín-Santos R, Porta M, et al.: Somatotype in panic patients. Anxiety 1996, 2:80–85.

    CAS  Article  PubMed  Google Scholar 

  13. 13.

    Bird HA, Tribe CR, Bacon PA: Joint hypermobility leading to osteoarthrosis and chondrocalcinosis. Ann Rheum Dis 1978, 37:203–211.

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Bridges AJ, Smith E, Reid J: Joint hypermobility in adults referred to rheumatologic clinics. Ann Rheum Dis 1992, 51:793–796.

    CAS  Article  PubMed  Google Scholar 

  15. 15.

    Gulbahar S, Sahin E, Baydar M, et al.: Hypermobility syndrome increase the risk for low bone mass. Clin Rheumatol 2005, 26:1–4.

    Article  Google Scholar 

  16. 16.

    • Garcia-Campayo J, Asso E, Alda M, et al.: Association between joint hypermobility syndrome and panic disorder: a case-control study. Psychosomatics 2010, 51:55–61. The most recent study on the subject confirmed a higher prevalence of JHS in patients with panic disorder and the association of severity symptoms between anxiety and JHS.

    Article  PubMed  Google Scholar 

  17. 17.

    Acasuso-Diaz M, Collantes-Estevez E: Joint hypermobility in patients with fibromyalgia syndrome. Arthritis Care Res 1998, 11:39–42.

    CAS  Article  PubMed  Google Scholar 

  18. 18.

    Grahame R, Edwards JC, Pitcher D, et al.: A clinical and echocardiographic study of patients with hypermobility syndrome. Ann Rheum Dis 1981, 40:541–546.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Pitcher D, Grahame R: Mitral valve prolapse and joint hypermobility: evidence for systemic connective tissue abnormality? Ann Rheum Dis 1982, 41:352–354.

    CAS  Article  PubMed  Google Scholar 

  20. 20.

    Devereux RB: Recent developments in the diagnosis and management of mitral valve prolapse. Curr Opin Cardiol 1995, 10:107–116.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Alpert MA, Sabati M, Kushner MG, et al.: Frequency of isolated panic attacks and panic disorder in mitral valve prolapse syndrome. Am J Cardiol 1992, 69:1489–1490.

    CAS  Article  PubMed  Google Scholar 

  22. 22.

    Sivaramakrishnan K, Alexander PJ, Saharsamaman N: Prevalence of panic disorder in mitral valve prolapse: a comparative study. Acta Psychiatr Scand 1994, 89:59–61.

    CAS  Article  PubMed  Google Scholar 

  23. 23.

    Katerndahl DA: Panic and prolapse: meta-analysis. J Nerv Ment Dis 1993, 181:539–544.

    CAS  Article  PubMed  Google Scholar 

  24. 24.

    Bulbena A, Duro JC, Porta M, Vallejo J: Anxiety disorders in the joint hypermobility syndrome. Lancet 1988, 2:694.

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    Bulbena A, Duró JC, Porta M, et al.: Anxiety disorder in the joint hypermobility syndrome. Psychiatry Res 1993, 43:59–68.

    Article  Google Scholar 

  26. 26.

    Martín-Santos R, Bulbena A, Porta M, Molina LI: Association between joint hypermobility syndrome and panic disorder. Am J Psychiatry 1998, 155:1578–1583.

    PubMed  Google Scholar 

  27. 27.

    Bulbena A, Agulló A, Pailhez G, et al.: Is joint hypermobility related to anxiety in a non-clinical population also? Psychosomatics 2004, 45:432–437.

    Article  PubMed  Google Scholar 

  28. 28.

    Benjamin J, Ben-Zion IZ, Dannon P, et al.: Lack of association between joint hyperlaxity and I: panic disorder, and II: reactivity to carbon dioxide in healthy volunteers. Hum Psychopharmacol 2001, 16:189–192.

    Article  PubMed  Google Scholar 

  29. 29.

    Gulpek D, Bayraktar E, Akbay SP, et al.: Joint hypermobility syndrome and mitral valve prolapse in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:969–973.

    Article  PubMed  Google Scholar 

  30. 30.

    Gülsün M, Doruk A, Uzun Ö, et al.: Hipermobilite sendromu olan klinik disi erkek Ö rnekleminde anksiyete bozukluklari [in Turkish]. Yeni Symp J 2006, 44:165–168.

    Google Scholar 

  31. 31.

    Gratacòs M, Nadal M, Martin-Santos R, et al.: A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders. Cell 2001, 106:367–379.

    Article  PubMed  Google Scholar 

  32. 32.

    Tabiner M, Youings S, Dennis N, et al.: Failure to find DUP25 in patients with anxiety disorders, in control individuals, or in previously reported positive control cell lines. Am J Hum Genet 2003, 72:535–538.

    CAS  Article  PubMed  Google Scholar 

  33. 33.

    Weiland Y, Kraus J, Speicher MR: A multiclot FISH assay does not detect DUP25 in control individuals or in reported positive control cells. Am J Hum Genet 2003, 72:1349–1352.

    CAS  Article  PubMed  Google Scholar 

  34. 34.

    • Roy-Byrne PP, Davidson KW, Kessler RC, et al.: Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 2008, 30:208–225. This recent review describes the many physical symptoms that can accompany anxiety and the long list of medical disorders than can explain them.

    Article  PubMed  Google Scholar 

  35. 35.

    Roca M, Gili M, Garcia-Garcia M, et al.: Prevalence and comorbidity of common mental disorders in primary care. J Affect Disord 2009, 119:52–58.

    CAS  Article  PubMed  Google Scholar 

  36. 36.

    García-Campayo J, Arevalo E, Claraco LM, et al.: A prevention programme for somatoform disorders is effective for affective disorders. J Affect Disord 2010, 122:124–132.

    Article  PubMed  Google Scholar 

  37. 37.

    • Pailhez G, Bulbena A, Fullana MA, Castaño J: Anxiety disorders and joint hypermobility syndrome: the role of collagen tissue. Gen Hosp Psychiatry 2009, 31:299. This short letter emphasizes that most medical symptoms presented by patients with anxiety could be explained by a collagen tissue disorder such as JHS.

    Article  PubMed  Google Scholar 

  38. 38.

    Gratacòs M, Nadal M, Martín-Santos R, et al.: A polymorphic genomic duplication on human chromosome 15 is a susceptibility factor for panic and phobic disorders. Cell 2001, 106:367–379.

    Article  PubMed  Google Scholar 

  39. 39.

    • Talati A, Ponniah K, Strug LJ, et al.: Panic disorder, social anxiety disorder, and a possible medical syndrome previously linked to chromosome 13. Biol Psychiatry 2008, 63:594–601. This study confirmed that patients with panic disorder or social anxiety disorder, as compared with controls, reported significantly more interstitial cystitis and MVP. First-degree relatives of probands with panic disorder or social anxiety disorder were also at increased risk of interstitial cystitis, MVP, thyroid problems, and headaches, regardless of whether the proband reported the same condition.

    CAS  Article  PubMed  Google Scholar 

  40. 40.

    Keer R, Grahame R: Hypermobility Syndrome. New York: Butterworth Heinemann; 2003.

    Google Scholar 

  41. 41.

    Davis M: Neurobiology of fear responses: the role of the amygdala. J Neuropsychiatry Clin Neurosci 1997, 9:382–402.

    CAS  PubMed  Google Scholar 

  42. 42.

    Grove G, Coplan JD, Hollander E: The neuroanatomy of 5-HT dysregulation and panic disorder. J Neuropsychiatry Clin Neurosci 1997, 9:198–208.

    CAS  PubMed  Google Scholar 

  43. 43.

    Rosenbaum JF, Biederman J, Hirshfeld DR, et al.: Behavioral inhibition in children: a possible precursor to panic disorder or social phobia. J Clin Psychiatry 1991; 52(Suppl 11):5–9.

    PubMed  Google Scholar 

  44. 44.

    Klein DF: False suffocation alarms, spontaneous panics, and related conditions: an integrative hypothesis. Arch Gen Psychiatry 1993, 50:306–317.

    CAS  PubMed  Google Scholar 

  45. 45.

    Bulbena A, Duró JC, Porta M, et al.: Clinical assessment of hypermobility of joints: assembling criteria. J Rheumatol 1992, 19:115–122.

    CAS  PubMed  Google Scholar 

  46. 46.

    Grahame R: Brighton diagnosis criteria for the benign joint hypermobility syndrome. Br J Rheumatol 2000, 27:1777–1779.

    CAS  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Javier Garcia-Campayo.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Garcia-Campayo, J., Asso, E. & Alda, M. Joint Hypermobility and Anxiety: The State of the Art. Curr Psychiatry Rep 13, 18–25 (2011). https://doi.org/10.1007/s11920-010-0164-0

Download citation

Keywords

  • Joint hypermobility
  • Anxiety
  • Association
  • Mitral valve prolapse